These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3153216)

  • 1. Plasma and erythrocyte concentrations of mercaptopurine after oral administration in children.
    Lönnerholm G; Kreuger A; Lindström B; Ludvigsson J; Myrdal U
    Pediatr Hematol Oncol; 1986; 3(1):27-35. PubMed ID: 3153216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variability of 6-mercaptopurine pharmacokinetics during oral maintenance therapy of children with acute leukemia.
    Lafolie P; Björk O; Hayder S; Ahström L; Peterson C
    Med Oncol Tumor Pharmacother; 1989; 6(4):259-65. PubMed ID: 2615529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral mercaptopurine in childhood leukemia: influence of food intake on bioavailability.
    Lönnerholm G; Kreuger A; Lindström B; Myrdal U
    Pediatr Hematol Oncol; 1989; 6(2):105-12. PubMed ID: 2702064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rectal bioavailability of 6-mercaptopurine in children with acute lymphoblastic leukaemia: partial avoidance of "first-pass" metabolism.
    Kato Y; Matsushita T; Uchida H; Egi S; Yokoyama T; Mohri K
    Eur J Clin Pharmacol; 1992; 42(6):619-22. PubMed ID: 1623901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-dependent kinetics of orally administered 6-mercaptopurine in children with leukemia.
    Kato Y; Matsushita T; Chiba K; Hijiya N; Yokoyama T; Ishizaki T
    J Pediatr; 1991 Aug; 119(2):311-6. PubMed ID: 1861221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of food intake on bioavailability of oral 6-mercaptopurine in children with acute lymphoblastic leukemia.
    Riccardi R; Balis FM; Ferrara P; Lasorella A; Poplack DG; Mastrangelo R
    Pediatr Hematol Oncol; 1986; 3(4):319-24. PubMed ID: 3153245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraindividual variation in 6-mercaptopurine pharmacokinetics during oral maintenance therapy of children with acute lymphoblastic leukaemia.
    Lafolie P; Hayder S; Björk O; Peterson C
    Eur J Clin Pharmacol; 1991; 40(6):599-601. PubMed ID: 1884741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large interindividual variations in the pharmacokinetics of oral 6-mercaptopurine in maintenance therapy of children with acute leukaemia and non-Hodgkin lymphoma.
    Lafolie P; Hayder S; Björk O; Ahström L; Liliemark J; Peterson C
    Acta Paediatr Scand; 1986 Sep; 75(5):797-803. PubMed ID: 3564948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and distribution of 6-mercaptopurine administered intravenously in children with lymphoblastic leukaemia.
    Jacqz-Aigrain E; Nafa S; Médard Y; Bessa E; Lescoeur B; Vilmer E
    Eur J Clin Pharmacol; 1997; 53(1):71-4. PubMed ID: 9349933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum azathioprine and 6-mercaptopurine levels and immunosuppressive activity after azathioprine in uremic patients.
    Odlind B; Hartvig P; Lindström B; Lönnerholm G; Tufveson G; Grefberg N
    Int J Immunopharmacol; 1986; 8(1):1-11. PubMed ID: 3957504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma pharmacokinetics and cerebrospinal fluid penetration of thioguanine in children with acute lymphoblastic leukemia: a collaborative Pediatric Oncology Branch, NCI, and Children's Cancer Group study.
    Lowe ES; Kitchen BJ; Erdmann G; Stork LC; Bostrom BC; Hutchinson R; Holcenberg J; Reaman GH; Woods W; Franklin J; Widemann BC; Balis FM; Murphy RF; Adamson PC
    Cancer Chemother Pharmacol; 2001 Mar; 47(3):199-205. PubMed ID: 11320662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of mercaptopurine: plasma drug and red cell metabolite concentrations after an oral dose.
    Welch J; Lennard L; Morton GC; Lilleyman JS
    Ther Drug Monit; 1997 Aug; 19(4):382-5. PubMed ID: 9263376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacokinetics of 6-mercaptopurine in children with acute lymphoblastic leukemia--interindividual and intraindividual variations].
    Hijiya N; Kato Y; Matsushita T; Yokoyama T
    Rinsho Ketsueki; 1989 Nov; 30(11):1931-6. PubMed ID: 2607612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The course of biological parameters and 6-mercaptopurine pharmacokinetics during maintenance treatment of children with acute lymphoblastic leukaemia.
    Hayder S; Björk O; Lafolie P
    Acta Paediatr Scand; 1990; 79(8-9):832-7. PubMed ID: 2239280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of tablet and liquid formulations of oral 6-mercaptopurine in children with acute lymphoblastic leukemia.
    Larsen RH; Hjalgrim LL; Grell K; Kristensen K; Pedersen LG; Brünner ED; Als-Nielsen B; Schmiegelow K; Nersting J
    Cancer Chemother Pharmacol; 2020 Jul; 86(1):25-32. PubMed ID: 32519032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of methotrexate on the bioavailability of oral 6-mercaptopurine.
    Balis FM; Holcenberg JS; Zimm S; Tubergen D; Collins JM; Murphy RF; Gilchrist GS; Hammond D; Poplack DG
    Clin Pharmacol Ther; 1987 Apr; 41(4):384-7. PubMed ID: 3470165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fat body mass and pharmacokinetics of oral 6-mercaptopurine in children with acute lymphoblastic leukemia.
    Zuccaro P; Guandalini S; Pacifici R; Pichini S; Di Martino L; Guiducci M; Giuliano M; Di Tullio MT; Pettoello Mantovani M
    Ther Drug Monit; 1991 Jan; 13(1):37-41. PubMed ID: 2057989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia.
    Lennard L; Lilleyman JS; Van Loon J; Weinshilboum RM
    Lancet; 1990 Jul; 336(8709):225-9. PubMed ID: 1973780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physiologically based pharmacokinetic modelling of methotrexate and 6-mercaptopurine in adults and children. Part 2: 6-mercaptopurine and its interaction with methotrexate.
    Ogungbenro K; Aarons L;
    J Pharmacokinet Pharmacodyn; 2014 Apr; 41(2):173-85. PubMed ID: 24651962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mercaptopurine Ingestion Habits, Red Cell Thioguanine Nucleotide Levels, and Relapse Risk in Children With Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group Study AALL03N1.
    Landier W; Hageman L; Chen Y; Kornegay N; Evans WE; Bostrom BC; Casillas J; Dickens DS; Angiolillo AL; Lew G; Maloney KW; Mascarenhas L; Ritchey AK; Termuhlen AM; Carroll WL; Relling MV; Wong FL; Bhatia S
    J Clin Oncol; 2017 May; 35(15):1730-1736. PubMed ID: 28339328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.